BIAFW
bioAffinity Technologies, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$0.70
+78.74%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 0.18x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.20x
- Price / sales
- 0.13x
- Price / cash flow
- -0.06x
Enterprise value
- Enterprise value
- -$249.3K
- EV / sales
- -0.04x
- EV / EBITDA
- 0.02x
- EV / EBIT
- 0.02x
- Market cap
- $745.4K
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026